Private Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $661K | Hold |
1,485
| – | – | 0.05% | 115 |
|
2025
Q1 | $720K | Sell |
1,485
-10
| -0.7% | -$4.85K | 0.06% | 103 |
|
2024
Q4 | $602K | Sell |
1,495
-930
| -38% | -$375K | 0.05% | 119 |
|
2024
Q3 | $1.13M | Buy |
2,425
+925
| +62% | +$430K | 0.09% | 87 |
|
2024
Q2 | $703K | Hold |
1,500
| – | – | 0.05% | 99 |
|
2024
Q1 | $627K | Sell |
1,500
-1,890
| -56% | -$790K | 0.05% | 97 |
|
2023
Q4 | $1.38M | Hold |
3,390
| – | – | 0.12% | 74 |
|
2023
Q3 | $1.18M | Sell |
3,390
-50
| -1% | -$17.4K | 0.11% | 70 |
|
2023
Q2 | $1.21M | Sell |
3,440
-90
| -3% | -$31.7K | 0.11% | 69 |
|
2023
Q1 | $1.11M | Buy |
+3,530
| New | +$1.11M | 0.11% | 75 |
|
2021
Q3 | – | Sell |
-14,355
| Closed | -$2.89M | – | 82 |
|
2021
Q2 | $2.89M | Sell |
14,355
-458
| -3% | -$92.3K | 0.27% | 51 |
|
2021
Q1 | $3.18M | Buy |
14,813
+934
| +7% | +$201K | 0.34% | 47 |
|
2020
Q4 | $3.28M | Buy |
13,879
+2,459
| +22% | +$581K | 0.36% | 47 |
|
2020
Q3 | $3.11M | Buy |
11,420
+776
| +7% | +$211K | 0.36% | 43 |
|
2020
Q2 | $3.09M | Buy |
10,644
+405
| +4% | +$118K | 0.42% | 46 |
|
2020
Q1 | $2.44M | Buy |
+10,239
| New | +$2.44M | 0.41% | 44 |
|
2014
Q4 | – | Sell |
-2,000
| Closed | -$225K | – | 172 |
|
2014
Q3 | $225K | Buy |
+2,000
| New | +$225K | 0.05% | 153 |
|